Volume | 807,749 |
|
|||||
News | (2) | ||||||
Day High | 109.59 | Low High |
|||||
Day Low | 106.37 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Natera Inc | NTRA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
109.00 | 106.37 | 109.59 | 107.51 | 108.51 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
16,871 | 807,749 | $ 107.96 | $ 87,206,278 | - | 36.90 - 110.09 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:35:44 | 3 | $ 105.38 | USD |
Natera (NTRA) Options Flow Summary
Natera Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
12.99B | 120.76M | - | 1.08B | -434.8M | -3.60 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Natera News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NTRA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 106.81 | 110.09 | 105.65 | 107.55 | 898,782 | 0.70 | 0.66% |
1 Month | 88.425 | 110.09 | 87.20 | 100.42 | 1,232,098 | 19.09 | 21.58% |
3 Months | 85.73 | 110.09 | 83.13 | 93.61 | 1,428,521 | 21.78 | 25.41% |
6 Months | 54.19 | 110.09 | 53.6183 | 78.35 | 1,414,921 | 53.32 | 98.39% |
1 Year | 53.06 | 110.09 | 36.90 | 64.89 | 1,278,785 | 54.45 | 102.62% |
3 Years | 86.59 | 129.09 | 26.10 | 59.70 | 1,342,615 | 20.92 | 24.16% |
5 Years | 22.50 | 129.09 | 16.87 | 59.18 | 1,111,321 | 85.01 | 377.82% |
Natera Description
Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result. |